Chemkart India Limited (BOM:544442)

Market Cap	1.66B
Revenue (ttm)	2.15B +5.7%
Net Income	196.58M -19.9%
EPS	17.26 -33.2%
Shares Out	12.10M
PE Ratio	7.93
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,000
Open	134.50
Previous Close	134.90
Day's Range	130.00 - 138.00
52-Week Range	87.00 - 262.00
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	May 18, 2026

About Chemkart India

Chemkart India Limited engages in the trading of various food and health ingredients in India. It offers amino acids, health supplements, herbal extracts, nucleotides, proteins, and vitamins, as well as sports nutrition products. The company also provides nutritional supplements and components, such as glycine, creatine monohydrate 200mesh, inositol, L-arginine, L-glutamine, L-carmitne, N-acetyl L-cysteine, taurine, L-glutathione, and whey protein concentrate. In addition, it engages in the trading and processing of nutraceutical products. The ...

• Industry: Drugs, Drug Proprietaries, and Druggists' Sundries
• Founded: 2020
• Country: India
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544442

Financial Performance

In fiscal year 2026, Chemkart India's revenue was 2.15 billion, an increase of 5.68% compared to the previous year's 2.03 billion. Earnings were 196.58 million, a decrease of -19.87%.